《BAD指南：原發(fā)性皮膚鱗狀細胞癌患者的管理》內容預覽

Summary: These guidelines for management of primary cutaneous squamous cell carcinoma presentevidence-based guidance for treatment, with identification of the strength of evidence available at thetime of preparation of the guidelines, and a brief overview of epidemiological aspects, diagnosis andinvestigation. These guidelines aim to ensure people with cutaneous squamous cell carcinomareceive the best possible treatment and care.
Disclaimer: These guidelines reflect the best published data available at the time the report wasprepared. Caution should be exercised in interpreting the data; the results of future studies mayrequire alteration of the conclusions or recommendations in this report. It may be necessary or evendesirable to depart from the guidelines in the interests of specific patients and special circumstances.Just as adherence to the guidelines may not constitute defence against a claim of negligence, sodeviation from them should not be necessarily deemed negligent.
Footnote: The authors are grateful to Professor PJ Barrett-Lee (Radiotherapy), Dr DAL Morgan(Oncology) Dr DN Slater (Pathology), Mr M Schenker (Plastic Surgery) and Mr A Langford (SkinCare Campaign) for their expert advice and comments on the manusc**t.

點擊下載完整版《BAD指南：原發(fā)性皮膚鱗狀細胞癌患者的管理》